AptarGroup, Inc. filed a Form 8-K on September 1, 2026, reporting the appointment of Gael Touya as a director and his assumption of the role of President and Chief Executive Officer, effective September 1, 2026.

Key Highlights

  • Board expanded: The Board of Directors increased in size from ten to eleven directors, effective August 29, 2026.
  • New director appointed: Gael Touya was appointed to the Board, effective September 1, 2026, with a term expiring at the 2028 annual meeting of stockholders.
  • CEO transition: Gael Touya became President and Chief Executive Officer effective September 1, 2026, succeeding Stephan B. Tanda, who retired from that position.
  • Prior role: Mr. Touya previously served as President of the Company's Aptar Pharma segment.
  • No additional director compensation: As an employee, Mr. Touya does not receive additional compensation for his service as a director.
  • No committee assignment: Mr. Touya is not expected to be appointed to any committee of the Board.

AptarGroup Board Changes and CEO Succession Details

According to the filing, AptarGroup's Board of Directors voted on August 29, 2026, to expand its membership from ten to eleven directors and to appoint Gael Touya to fill the newly created seat. Mr. Touya's appointment as a director became effective September 1, 2026, and the filing states his term will expire at the Company's 2028 annual meeting of stockholders and until his successor is duly elected and qualified.

The filing notes that Mr. Touya's elevation to President and Chief Executive Officer was previously disclosed in a Form 8-K filed on March 17, 2026. AptarGroup disclosed that Stephan B. Tanda retired from the President and Chief Executive Officer position on September 1, 2026. Before assuming the top executive role, Mr. Touya served as President of the Company's Aptar Pharma segment, according to the filing.

The filing further states that "there are no arrangements or understandings between Mr. Touya and any other persons pursuant to which Mr. Touya was appointed as a director of the Company." AptarGroup also disclosed that there are no family relationships between Mr. Touya and any director or executive officer of the Company, and that Mr. Touya has no direct or indirect interest in any transaction required to be disclosed under Item 404(a) of Regulation S-K. The compensation arrangements for Mr. Touya's service as President and Chief Executive Officer were described as previously disclosed in the March 17, 2026 Form 8-K. The filing is for NYSE:ATR.

What Was Disclosed

AptarGroup reported the Board's expansion to eleven members, the appointment of Gael Touya as a director, and his transition into the President and CEO role effective September 1, 2026, succeeding retiring CEO Stephan B. Tanda.